Global Diagnostic Nuclear Drug Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Diagnostic Nuclear Drug Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Tc-99m
  • 1.4.3 F-18
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Diagnostic Nuclear Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Oncology
  • 1.5.3 Cardiology
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Diagnostic Nuclear Drug Market Perspective (2015-2026)
• 2.2 Diagnostic Nuclear Drug Growth Trends by Regions
  • 2.2.1 Diagnostic Nuclear Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Diagnostic Nuclear Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Diagnostic Nuclear Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Diagnostic Nuclear Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Diagnostic Nuclear Drug Players by Market Size
  • 3.1.1 Global Top Diagnostic Nuclear Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Diagnostic Nuclear Drug Market Concentration Ratio
  • 3.2.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2019
• 3.3 Diagnostic Nuclear Drug Key Players Head office and Area Served
• 3.4 Key Players Diagnostic Nuclear Drug Product Solution and Service
• 3.5 Date of Enter into Diagnostic Nuclear Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2021-2026)

5 Diagnostic Nuclear Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Diagnostic Nuclear Drug Market Size by Application (2015-2020)
• 5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Diagnostic Nuclear Drug Market Size (2015-2020)
• 6.2 Diagnostic Nuclear Drug Key Players in North America (2019-2020)
• 6.3 North America Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 6.4 North America Diagnostic Nuclear Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Diagnostic Nuclear Drug Market Size (2015-2020)
• 7.2 Diagnostic Nuclear Drug Key Players in Europe (2019-2020)
• 7.3 Europe Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 7.4 Europe Diagnostic Nuclear Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Diagnostic Nuclear Drug Market Size (2015-2020)
• 8.2 Diagnostic Nuclear Drug Key Players in China (2019-2020)
• 8.3 China Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 8.4 China Diagnostic Nuclear Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Diagnostic Nuclear Drug Market Size (2015-2020)
• 9.2 Diagnostic Nuclear Drug Key Players in Japan (2019-2020)
• 9.3 Japan Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 9.4 Japan Diagnostic Nuclear Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Diagnostic Nuclear Drug Market Size (2015-2020)
• 10.2 Diagnostic Nuclear Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Diagnostic Nuclear Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Diagnostic Nuclear Drug Market Size (2015-2020)
• 11.2 Diagnostic Nuclear Drug Key Players in India (2019-2020)
• 11.3 India Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 11.4 India Diagnostic Nuclear Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Diagnostic Nuclear Drug Market Size (2015-2020)
• 12.2 Diagnostic Nuclear Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Diagnostic Nuclear Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Diagnostic Nuclear Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bracco Imaging
  • 13.1.1 Bracco Imaging Company Details
  • 13.1.2 Bracco Imaging Business Overview and Its Total Revenue
  • 13.1.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
  • 13.1.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2015-2020))
  • 13.1.5 Bracco Imaging Recent Development
• 13.2 Bayer
  • 13.2.1 Bayer Company Details
  • 13.2.2 Bayer Business Overview and Its Total Revenue
  • 13.2.3 Bayer Diagnostic Nuclear Drug Introduction
  • 13.2.4 Bayer Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.2.5 Bayer Recent Development
• 13.3 Curium Pharmaceuticals
  • 13.3.1 Curium Pharmaceuticals Company Details
  • 13.3.2 Curium Pharmaceuticals Business Overview and Its Total Revenue
  • 13.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Introduction
  • 13.3.4 Curium Pharmaceuticals Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.3.5 Curium Pharmaceuticals Recent Development
• 13.4 Nordion
  • 13.4.1 Nordion Company Details
  • 13.4.2 Nordion Business Overview and Its Total Revenue
  • 13.4.3 Nordion Diagnostic Nuclear Drug Introduction
  • 13.4.4 Nordion Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.4.5 Nordion Recent Development
• 13.5 Triad Isotopes
  • 13.5.1 Triad Isotopes Company Details
  • 13.5.2 Triad Isotopes Business Overview and Its Total Revenue
  • 13.5.3 Triad Isotopes Diagnostic Nuclear Drug Introduction
  • 13.5.4 Triad Isotopes Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.5.5 Triad Isotopes Recent Development
• 13.6 Lantheus
  • 13.6.1 Lantheus Company Details
  • 13.6.2 Lantheus Business Overview and Its Total Revenue
  • 13.6.3 Lantheus Diagnostic Nuclear Drug Introduction
  • 13.6.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.6.5 Lantheus Recent Development
• 13.7 GE Healthcare
  • 13.7.1 GE Healthcare Company Details
  • 13.7.2 GE Healthcare Business Overview and Its Total Revenue
  • 13.7.3 GE Healthcare Diagnostic Nuclear Drug Introduction
  • 13.7.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.7.5 GE Healthcare Recent Development
• 13.8 China Isotope & Radiation
  • 13.8.1 China Isotope & Radiation Company Details
  • 13.8.2 China Isotope & Radiation Business Overview and Its Total Revenue
  • 13.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
  • 13.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.8.5 China Isotope & Radiation Recent Development
• 13.9 Jubilant Pharma
  • 13.9.1 Jubilant Pharma Company Details
  • 13.9.2 Jubilant Pharma Business Overview and Its Total Revenue
  • 13.9.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
  • 13.9.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.9.5 Jubilant Pharma Recent Development
• 13.10 Eli Lilly
  • 13.10.1 Eli Lilly Company Details
  • 13.10.2 Eli Lilly Business Overview and Its Total Revenue
  • 13.10.3 Eli Lilly Diagnostic Nuclear Drug Introduction
  • 13.10.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 13.10.5 Eli Lilly Recent Development
• 13.11 Novartis
  • 10.11.1 Novartis Company Details
  • 10.11.2 Novartis Business Overview and Its Total Revenue
  • 10.11.3 Novartis Diagnostic Nuclear Drug Introduction
  • 10.11.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 10.11.5 Novartis Recent Development
• 13.12 SIEMENS
  • 10.12.1 SIEMENS Company Details
  • 10.12.2 SIEMENS Business Overview and Its Total Revenue
  • 10.12.3 SIEMENS Diagnostic Nuclear Drug Introduction
  • 10.12.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 10.12.5 SIEMENS Recent Development
• 13.13 Dongcheng
  • 10.13.1 Dongcheng Company Details
  • 10.13.2 Dongcheng Business Overview and Its Total Revenue
  • 10.13.3 Dongcheng Diagnostic Nuclear Drug Introduction
  • 10.13.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 10.13.5 Dongcheng Recent Development
• 13.14 Navidea
  • 10.14.1 Navidea Company Details
  • 10.14.2 Navidea Business Overview and Its Total Revenue
  • 10.14.3 Navidea Diagnostic Nuclear Drug Introduction
  • 10.14.4 Navidea Revenue in Diagnostic Nuclear Drug Business (2015-2020)
  • 10.14.5 Navidea Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer